Cue Health awarded $28m BARDA contract for multiplex test for Flu, RSV, and COVID-19
Healthcare technology company Cue Health (Nasdaq: HLTH) announced that it has been awarded a contract worth approximately $28 million by the Biomedical Advanced Research and ... Read More
Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More
PharmEasy to acquire 66.1% stake in Thyrocare Technologies for $61m
API Holdings Ltd, the holding company for Indian online pharmacy store PharmEasy, has agreed to acquire a stake of 66.1% in Thyrocare Technologies, a chain ... Read More